Jade Biosciences, Inc. (JBIO) stock
Close on Nov 13, 2026Market cap $1.03BP/E –Yield –
Jade Biosciences statistics
59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 5, 2027 (estimated, before the open)
- Last ex-dividend date
- Apr 29, 2025
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.33
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 235.3%
- 10.8%
- Shares Change (QoQ)
- 28.8%
- 0.50%
- Float
- 49M
- 49M
- Shares Held by Insiders
- 23.4%
- 11.7%
- Shares Held by Institutions
- 114.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 10M
- –
- Short Interest Change
- -7.46%
- -0.80%
- Short % of Float
- 21.3%
- 9.01%
- Short % of Shares Outstanding
- 16.3%
- 6.30%
- Days to Cover
- 14.10
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $28.00
- –
- 52-Week Low
- $9.51
- –
- 20-Day Moving Average
- $14.94
- –
- 50-Day Moving Average
- $15.32
- –
- 200-Day Moving Average
- $18.23
- –
- Average True Range (14)
- $0.97
- –
- Price Change (1 Week)
- 7.10%
- -1.15%
- Price Change (1 Month)
- 17.3%
- -4.87%
- Price Change (3 Months)
- -31.2%
- -21.0%
- Price Change (6 Months)
- -30.9%
- -20.6%
- Price Change (YTD)
- 4.60%
- -23.6%
- Price Change (1 Year)
- 61.4%
- -22.4%
- Price Change (3 Years)
- -96.7%
- -29.5%
- Price Change (5 Years)
- -97.9%
- -77.9%
- Average Volume (10 Days)
- 897,409
- –
- Average Volume (20 Days)
- 810,360
- –
- Average Volume (90 Days)
- 896,898
- –
- Relative Volume
- 0.66
- 0.70
- Relative Strength Index (14)
- 58.1
- 43.4
- Volatility (1 Year)
- 71.9%
- 80.1%
- Beta (5 Years)
- 0.80
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -47.8%
- -49.9%
- Return on Assets (ROA)
- -44.0%
- -40.6%
- Return on Capital Employed (ROCE)
- -37.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 14.93
- 3.30
- Quick Ratio
- 14.61
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$2.79M
- -$689.41K
- Employee Count
- 55
- 74
- WACC
- 9.12%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $461.21M
- $17.76M
- Net Cash Per Share
- $7.25
- $0.80
- Equity (Book Value)
- $439.92M
- $53.89M
- Book Value Per Share
- $6.92
- $1.50
- Tangible Book Value
- $439.92M
- $27.13M
- Working Capital
- $439.68M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -14.9%
- -21.8%
Taxes and interestIndustry
- Income Tax
- $89.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 18.29
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | JBIO | S&P 500 | Difference | JBIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +20.3% | -3.0% | +23.3 pts | ||
| 3 months | -32.2% | -2.8% | −29.4 pts | ||
| Year to date | +4.6% | +11.5% | −6.9 pts | ||
| 1 year | +66.7% | +13.5% | +53.3 pts | ||
| 3 years | -96.2% | +77.7% | −173.9 pts | -66.3% | +21.1% |
| 5 years | -97.8% | +72.6% | −170.4 pts | -53.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
10M JBIO shares were sold short on Oct 30, 2026, down 7.5% from the previous report, or 21.28% of the shares available to trade. At recent volumes it would take 14.1 days to buy them back. Over the last 20 sessions, 61.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 10,374,791 | -7.5% | 735,575 | 14.1 |
| Oct 15, 2026 | 11,210,801 | -7.5% | 1,031,218 | 10.9 |
| Sep 30, 2026 | 12,119,108 | +10.3% | 1,069,456 | 11.3 |
| Sep 15, 2026 | 10,982,905 | +9.9% | 933,970 | 11.8 |
| Aug 31, 2026 | 9,994,410 | +3.6% | 606,567 | 16.5 |
| Aug 14, 2026 | 9,650,429 | +11.0% | 951,158 | 10.2 |
| Jul 31, 2026 | 8,690,697 | +15.4% | 755,922 | 11.5 |
| Jul 15, 2026 | 7,528,320 | -7.6% | 1,052,173 | 7.2 |
| Jun 30, 2026 | 8,148,753 | +64.7% | 1,679,029 | 4.8 |
| Jun 15, 2026 | 4,947,659 | +56.4% | 1,595,743 | 3.1 |
| May 29, 2026 | 3,163,082 | -6.9% | 582,751 | 5.4 |
| May 15, 2026 | 3,398,202 | +9.7% | 443,565 | 7.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?